Taking a leave of absence, Ampio Pharmaceuticals CEO passes baton to a new board member; Axel Hoos' cancer biotech lands a CFO
Before you dive into your Thanksgiving feasts, Peer Review has some appointments to share:
→ Mike Macaluso will be taking a one-year medical leave of absence from his duties as chairman and CEO of Englewood, CO-based Ampio Pharmaceuticals after disclosing last month that he is undergoing treatment. Michael Martino took a seat at the board of directors at the time of that October announcement, and the company will now be entrusted to him as interim chairman and CEO while Macaluso is away. Ampio also revealed a month ago that COO Holli Cherevka was elevated to president and COO, while Howard Levy — a CSL Behring and Novo Nordisk vet who retired from Catalyst Biosciences this summer — was named CMO. Dicerna chairman Kevin Buchi has also been added to Ampio’s board of directors.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.